In Dr Smith's written evidence, he described the CSM as having gained "some comfort" from being told that efforts were being made to secure UK independence of foreign suppliers of clotting factor concentrates.

Chronology Information

Date:

Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates